The store will not work correctly when cookies are disabled.
US8785477, Vildagliptin
ID: ALA3665969
Cas Number: 1360862-63-0
PubChem CID: 5251896
Max Phase: Preclinical
Molecular Formula: C17H25N3O2
Molecular Weight: 303.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2
Standard InChI: InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2
Standard InChI Key: SYOKIDBDQMKNDQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
1.6421 -1.2737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4600 -1.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4000 -1.8100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8500 -1.5200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4800 -2.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6000 -2.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1200 -2.5800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5400 -1.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2300 -0.3200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8500 -0.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4900 -0.6700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.1627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0293 1.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0913 3.4665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1546 4.0227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1758 4.2708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5510 3.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5093 4.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7081 6.1262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2545 5.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0947 6.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8343 7.4639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 2 1 0
6 8 1 0
8 9 1 0
9 10 1 0
10 4 1 0
9 11 1 0
11 2 1 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
20 21 1 0
21 22 3 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.41 | Molecular Weight (Monoisotopic): 303.1947 | AlogP: 1.17 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.36 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.03 | CX LogP: -0.22 | CX LogD: -1.85 |
Aromatic Rings: ┄ | Heavy Atoms: 22 | QED Weighted: 0.82 | Np Likeness Score: -0.50 |
References
1. (2014) Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof, |